Table 4.
Clinical factor | Tumor factor* |
---|---|
No limit up to BMI 41.5 kg/m2 | Minimum size 1.0 cm longest diameter on radiographic imaging22 |
Tumor location limited by safety, e.g. proximity to vessels and bowel wall | Less than 25% of tissue necrosis preferred. |
No effect of recent or ongoing bevacizumab exposure | At least 50% of tumor cells in tissue obtained is preferred unless it is recognized that signal may reflect stroma and tumor |
No limit to number or kinds of prior treatment19 |
Usable for IHC and/or RPPA